Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

  • Eleni Gavriilaki*
  • , Myriam Labopin
  • , Ioanna Sakellari
  • , Urpu Salmenniemi
  • , Ibrahim Yakoub-Agha
  • , Victoria Potter
  • , Ana Berceanu
  • , Alessandro Rambaldi
  • , Inken Hilgendorf
  • , Nicolaus Kröger
  • , Stephan Mielke
  • , Tsila Zuckerman
  • , Jaime Sanz
  • , Alessandro Busca
  • , Hakan Ozdogu
  • , Achilles Anagnostopoulos
  • , Bipin Savani
  • , Sebastian Giebel
  • , Ali Bazarbachi
  • , Alexandros Spyridonidis
    • Arnon Nagler, Mohamad Mohty
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology